Nanological

nanological.es ↗ ·Madrid ·Seed

Nanological is a Madrid-based deep-tech medical device company that develops rapid point-of-care diagnostics for sepsis. Its SOMIA platform combines optomechanical sensing with AI algorithms to identify pathogens directly from blood samples in under 30 minutes, without culturing or labelling. The company was founded in 2021 as a spin-off of the Institute of Materials Science of Madrid (ICMM-CSIC) and is based at the Madrid Scientific Park. In November 2023 it raised a €600,000 first round led by Clave Capital through its Clave Innohealth FCR fund. It has also received €325,000 in public funding from CDTI's NEOTEC 2022 programme and support from EU programmes including Women TechEU, and it has won the Health to Market prize.

Founded

2021

Founders

Total funds raised

€600K

SectorsMedtech, Diagnostics, Deeptech, AI Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Suggest a correction

Founders

Blanca Caballero

CEO & Co-founder

Daniel Ramos

Co-founder & Chief Scientific Advisor

José Francisco Caballero

CFO & Co-founder

Global models 5

Karius

United States · kariusdx.com ↗

Identifies pathogens directly from a blood sample without culture to speed up diagnosis of serious infections and sepsis, selling to hospitals.

~$265MComparable

Inflammatix

United States · inflammatix.com ↗

Rapid point-of-care blood test with machine-learning interpretation that triages sepsis and infection type in about 30 minutes, sold to hospital emergency departments.

~$200MComparable

Cytovale

United States · cytovale.com ↗

Rapid blood-based sepsis diagnostic combining novel cell mechanics sensing with algorithms for emergency departments, making money from instrument and cartridge sales.

~$150MComparable

T2 Biosystems

United States · t2biosystems.com ↗

Culture-independent detection of sepsis-causing pathogens directly from whole blood in a few hours, sold to hospitals as an instrument plus test panels.

~$100M (pre-IPO)Comparable

Qvella

Canada · qvella.com ↗

Rapid sepsis diagnostic platform that shortens pathogen identification from blood, targeting hospital labs with a device-plus-consumables model.

~$60MComparable

In the same niche 48 others

See all in the Start-ups Map →

Universal Diagnostics

Venture Debt · €25.7M

Biohope

Madrid

No stage disclosed · €15M

iPremom

Valencia

Seed · €15M

+42 more →

Notes: Most funded first

Investors 1

Open as list →

Clave Capital

clavemayor.com

Led Seed 2023 Spain

Funding rounds 1

Date	Round	Amount	Lead
2023-11-23	Seed (estimated)	€600K	Clave Capital

News 5

Open as list →

Published	Article
2026-06-25	10 years of healthstart madri+d: driving healthcare startups ↗ Capital-Riesgo.es 2026-06-25
2025-12-27	La cofundadora de Nanological, reconocida entre las 40 líderes europeas de Women TechEU ↗ EEN Madrid 2025-12-27
2025-12-19	Nueve startups deep tech culminan la cuarta edición de CaTaPull UP, el programa de escalado del Parque Científico de Madrid ↗ Farmabiotec 2025-12-19
2025-11-19	La madrileña Nanological desarrolla un test con IA capaz de detectar sepsis en minutos ↗ MuyPymes 2025-11-19
2023-11-22	Nanological cierra una ronda de financiación de €600.000 liderada por Clave Capital ↗ Biotech Spain 2023-11-22